ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2015 American Transplant Congress

    Renal Cell Carcinoma in the Native Kidney in Dialysis and Kidney Transplantation Recipients. Different Entities?

    K. Yamaçake, W. Nahas, H. Kanashiro, R. Kato, A. Bull, I. Antonopoulos, R. Falci, A. Piovesan.

    Division of Urology, Renal Transplantation Unit, University of São Paulo, São Paulo, SP, Brazil.

    Purpose: Renal Cell Carcinoma (RCC) has a high incidence in patients with acquired cystic kidney disease (ACKD) due to hemodialysis. It has been reported that…
  • 2015 American Transplant Congress

    Furthering the Link Between Ischemia and Immunity: Development of New Antibody Following Prolonged Delayed Graft Function

    A. Gilbert,1 E. Hall,1 O. Timofeeva,2 M. Awwad,2 M. Grafals,1 P. Weems,1 D. Li,2 S. Rosen-Bronson,2 J. Moore,1 B. Javaid,1 M. Cooper.1

    1Department of Surgery, MedStar Georgetown Transplant Institute, Washington, DC; 2Department of Pathology, MedStar Georgetown Transplant Institute, Washington, DC.

    Introduction The purpose of this study is to examine the relationship between prolonged ischemia (delayed graft function - DGF) and the development of de novo…
  • 2015 American Transplant Congress

    Antibody-Mediated Rejection of Renal Allografts by CCR5-/- Mice Does Not Require CD8 T Cells

    N. Kohei,1 T. Tanaka,1 H. Tsuda,1 N. Dvorina,1 K. Tanabe,2 W. Baldwin,1 R. Fairchild.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.

    Antibody-mediated acute and chronic graft injury remains a major cause of renal allograft loss. Mechanisms underlying these injuries remain unclear due in part to the…
  • 2015 American Transplant Congress

    Steroid Free Immunosuppression Protocol in Pediatric Kidney Transplant Recipients Using Alemtuzumab: A Retrospective Single Center Study

    R. Shah,1 Z. Kadry,1 S. Wassner,2 D. Kees-Folts,2 M. Freeman,2 P. Freeman,1 B. Olenowski,1 A. Jain.1

    1Surgery, Hershey Medical Center, Hershey, PA; 2Pediatric Nephrology, Hershey Medical Center, Hershey, PA.

    Background: Steroid free immunosuppression is attractive in pediatric kidney transplantation (KTx). Aim of the present study is to examine the patient survival, graft survival, rate…
  • 2015 American Transplant Congress

    Kidney Double Negative TCR αβ + Cells: Newly Described Intra-Renal Kidney Lymphocytes That Respond to Ischemia Reperfusion in Mice

    M. Martina,1 S. Bandapalle,2 S. Noel,2 A. Saxena,1 A. Hamad,1 H. Rabb.2

    1Pathology, Johns Hopkins University, Baltimore, MD; 2Medicine, Johns Hopkins University, Baltimore, MD.

    Background TCRαβ+CD4-CD8- double negative (DN) T cells with immunoregulatory function are a significant component of T cells residing in the kidney. The exact role of…
  • 2015 American Transplant Congress

    Efficacy and Safety of Three Different Treatment Regimen in De Novo Renal Transplant Patients: Month 48 Follow-Up Results of the HERAKLES Trial

    C. Sommerer,1 K. Budde,1 V. Kliem,1 O. Witzke,1 M. Guba,1 J. Jacobi,1 B. Vogt,3 I. Hauser,1 P. Reinke,1 R. Stahl,1 T. Rath,1 M. Porstner,2 D. Baeumer,2 M. Zeier,1 W. Arns,1 F. Lehner.1

    1Herakles Study Group, Germany; 2Novartis Pharma, Nuremberg, Germany; 3Herakles Study Group, Switzerland.

    Aim: To compare safety and efficacy of 3 different immunosuppressive (IS) regimen 4years after renal transplantation (Tx).Methods: 802 patients (pts) were included in this 1year,…
  • 2015 American Transplant Congress

    Effect of Patient Functional Status on the Associations Between Kidney Transplant Waitlisting, Race, and U.S. Region

    L. Plantinga, R. Patzer, S. Pastan, C. Bowling.

    Emory University, Atlanta.

    Background: Black race and Southeastern residence at the start of end-stage renal disease (ESRD) are associated with reduced access to the U.S. kidney transplant waitlist,…
  • 2015 American Transplant Congress

    Impact of Abdominal Aortic Calcification in Living Kidney Donors

    Y. Yoon,1 K. Choi,2 D. Joo,3 K. Huh,3 M. Kim,3 S. Kim,3 Y. Kim,3 S. Yang,2 W. Han.1

    1Department of Urology, Yonsei University College of Medicine, Seoul, Korea; 2Department of Urology, CHA University, Seongnam-si, Korea; 3Department of Transplantation Surgery, Yonsei University College of Medicine, Seoul, Korea.

    Introduction: To assess the association between abdominal aortic calcification (AAC) and renal function of living kidney donor and to evaluate the value of an AAC…
  • 2015 American Transplant Congress

    Gender Disparity in Infections After Kidney Transplantation

    S. Bae, L. Kucirka, C. Durand, B. Orandi, R. Avery, D. Segev.

    Johns Hopkins, Baltimore, MD.

    BACKGROUND: Female gender has been suggested as a risk factor for infection after kidney transplant (KT). Preliminary studies have reported that sex hormones such as…
  • 2015 American Transplant Congress

    Deficiency of Naturally Occurring Anti-Angiogenic Antibodies Associate With the Development of Metastatic Cancer Post Renal Transplantation and Patient Death

    R. Carroll,1 A. Phillippe,2 R. Catar,2 H. Heidecke,2 D. Dragun.2

    1Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia; 2Centre for Cardiovascular Research, Charite Hospital, Berlin, Germany.

    We assessed the presence of naturally occurring blocking antibodies to mediators of vascularisation and metastasis in Kidney Transplant Recipients (KTR) with metastatic cancer (n=11), non…
  • « Previous Page
  • 1
  • …
  • 518
  • 519
  • 520
  • 521
  • 522
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences